211 filings
Page 6 of 11
8-K
6yrgby
5 Mar 20
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
4:07pm
8-K
c0fumguzp26l9g9zbqq
13 Feb 20
Regulation FD Disclosure
8:00am
8-K
ur7p 80jge
3 Feb 20
Corvus Pharmaceuticals Presents Updated Clinical Data from its Phase 1/1b Clinical Trial of CPI-818 at the 12th Annual T-Cell Lymphoma Forum
8:00am
8-K
rzn3ju 74
16 Dec 19
Departure of Directors or Certain Officers
4:00pm
8-K
upmcfc1
9 Dec 19
Selective ITK inhibitor was well tolerated with demonstration of specific target occupancy
6:30am
8-K
44jr zndhugn9bw84b
12 Nov 19
Entry into a Material Definitive Agreement
9:00am
8-K
h9c3 css6
8 Nov 19
Regulation FD Disclosure
4:02pm
8-K
0bjv8o
29 Oct 19
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2019 Financial Results
4:51pm
8-K
xrirc zaog4z
1 Aug 19
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2019 Financial Results
4:10pm
8-K
s7vkco0cl 1ftf
24 Jun 19
Submission of Matters to a Vote of Security Holders
12:00am
8-K
8vukg
3 Jun 19
Regulation FD Disclosure
8:30am
S-8
zf1sk5
9 May 19
Registration of securities for employees
4:40pm
8-K
9wx9 rity4915
9 May 19
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2019 Financial Results
4:04pm
DEFA14A
owry5
24 Apr 19
Additional proxy soliciting materials
4:14pm
8-K
uhsumodo1zwxa
7 Mar 19
Corvus Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
4:15pm